Mori Building Unveils Massive Urban Regeneration Project in Central Tokyo
22.8.2019 07:00:00 EEST | Business Wire | Press release
Mori Building Co., Ltd., a leading urban landscape developer, has begun construction on its “Toranomon-Azabudai District Category 1 Urban Redevelopment Project,” a massive urban regeneration project aimed at revitalizing a large area of central Tokyo. A groundbreaking ceremony was held on August 5 and project completion is scheduled for the end of March 2023.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190821005445/en/
Image of Office Lobby (Graphic: Business Wire)
The core concept of the Toranomon-Azabudai Project is that of a “Modern Urban Village,” a unique neighborhood that will combine the sophistication of a megalopolis with the intimacy of a small village in the heart of Tokyo. It will cover an area of approximately 8.1 hectares, similar to that of New York’s Rockefeller Center, and will feature extensive greenery totaling 24,000 m2 including a 6,000 m2 central square. Total floor area will be 860,400 m2, including 213,900 m2 of office space and about 1,400 residential units. Some 20,000 office workers and 3,500 residents will work and live there, and 25-30 million people per year are expected to visit this totally new city-within-a-city.
Its physical structures will incorporate cutting-edge seismic designs and technologies, with dedicated power stations supplying electricity to the whole neighborhood. The project is designed to provide a safe city that will allow people to carry on living and working even in the event of a major disaster on the scale of the Great East Japan Earthquake. Mori Building’s unsurpassed safety and security measures are designed to create cities to escape to, rather than flee from.
Green & Wellness for enhanced lifestyles
The Toranomon-Azabudai Project will create a “unique people-centered space” by blending diverse elements and creating a world of its own. The project will seamlessly weave offices, residences, a hotel, an international school, retail shops, restaurants and cultural facilities into the fabric of everyday life, encompassing work, learning, recreation, interaction and relaxation. Built around innovative features that will include a village-like plaza surrounded by greenery, the project will create an urban space where people achieve harmony with nature as well as connecting with and inspiring each other with creativity. Far more than a mere grouping of buildings, the project will realize an integrated social ecosystem based on a people-centered approach to planning.
The core theme of the project is the huge 6,000 m2 central square offering “Green & Wellness” that will allow people from its diverse communities to gather and meet. A significant proportion of the site, including spaces on top of podium buildings, will be covered with greenery to take advantage of the stepped architecture. There will be more than two hectares of green space, including the central square, creating a seamless urban oasis filled with trees, flowers and waterscapes.
100% of the electricity supplied to the entire neighborhood will be from renewable sources, which will meet the targets stipulated in the RE100 international environmental initiative led by the UK’s Climate Group. The mental and physical wellbeing of people living and working in the area will be supported with wellness programs involving medical facilities, sports facilities, a food market, restaurants and the environment of the central square. Mori Building will apply for project certification under the WELL Building Standard™ of the International WELL Building Institute™.
A city where various aspects of people's lives will be connected seamlessly
The Toranomon-Azabudai Project will result in an urban environment where various aspects of people’s lives— working, living, relaxing, getting together, learning, playing—will be seamlessly connected. Rather than designing the city around facilities such as offices, residences and hotels, Mori Building is approaching this development from the perspective of human activity by removing the barriers between facilities. Here, various facilities will interact and collaborate, offering people the opportunity of totally new lifestyles; a place where people can spend their life in harmony with nature, where they will meet and live in a community, and where they can live creative and stimulating lives. The entire city, full of greenery, will become a place of learning, a workplace, a home, and a playground.
Leading global innovators help to implement a “Modern Urban Village” concept
The world's top creators were assembled to realize the design of this unique “Modern Urban Village,” with Mori Building playing a pivotal role in the project organization. Public realm and lower level architecture were created by Heatherwick Studio from the UK, led by Thomas Heatherwick, the designer and creator of the London 2012 Olympic Cauldron. The three skyscrapers were designed by Pelli Clarke Pelli Architects from the USA under the direction of the late César Pelli and Fred Clarke. The retail space was designed by Sou Fujimoto Architects of Japan, led by Sou Fujimoto. Other noted experts from around the world also participated.
|
Main participating architects, creators and designers |
|
• Thomas Heatherwick, |
|
Founder of Heatherwick Studio |
|
• César Pelli (dec.) |
|
Pelli Clarke Pelli Architects |
|
• Fred Clarke |
|
Pelli Clarke Pelli Architects |
|
• Sou Fujimoto, |
|
Sou Fujimoto Architects (Japan) |
|
• Glenn Pushelberg and George Yabu, |
|
Yabu Pushelberg (Canada) |
|
• Marco Costanzi, |
|
Marco Costanzi Architects (Italy) |
|
• Soo K. Chan, SCDA (Singapore) |
|
Tyler Brûlé, Winkreative (UK) |
Connecting the “Hills” and creating a new cultural and economic heart of Tokyo
Mori Building’s strategic area, which incorporates the district encompassed by the Toranomon-Azabudai Project, straddles the center of Tokyo’s Minato City. The area has long had an international feel to it; many foreign-minded companies gravitate here, and it hosts a large number of foreign residents. Rich in international flavors, diversity and culture, this area has extremely high potential to become a new international hub of Tokyo.
The new project site is adjacent to Mori Building’s ARK Hills complex at the midpoint between Roppongi Hills, the “Cultural Heart of Tokyo”, and Toranomon Hills, the “Global Business Hub”. These existing Hills projects will be linked by the Toranomon-Azabudai Project; this will enhance the evolution of the entire area, creating a new international urban focal point as well as a new cultural and economic hub in the heart of Tokyo.
|
Project overview |
|
|
Project name: |
Toranomon-Azabudai District Category 1 Urban Redevelopment Project |
|
Project executor: |
Toranomon-Azabudai District Urban Redevelopment Association |
|
Site area: |
Approx. 8.1 hectares |
|
Ground area: |
Approx. 63,900 square meters |
|
Total floor area: |
Approx. 860,400 square meters |
|
Buildings: |
Residences (1,400 units), offices (approx. 213,900 m2), retail facilities (approx. 150 shops), hotel (approx. 120 rooms), international school (approx. 14,000 m2), central square (approx. 6,000 m2), cultural facilities (approximately 9,000 m2) |
|
Greenery: |
Approx. 2.4 hectares |
|
Parking: |
Approx. 1,880 spaces |
|
Project cost: |
Approx. JPY 580 billion |
|
Members: |
285 rights holders (as of March, 2019) |
|
Construction start: |
August 5, 2019 |
|
Planned completion: |
March 31, 2023 |
|
If you wish to edit the images, or you would like materials not included in these downloads (e.g. designers’ photographs) please contact Weber Shandwick Japan by email to moribldg@webershandwick.com. |
|
Download link:(by Sep 23rd, 2019) |
|
Password:mori20xx |
About Mori Building
Mori Building is an innovative urban developer based in Tokyo. The company is committed to maximizing the magnetic power of cities by creating and nurturing safe, sustainable and cosmopolitan urban centers based on its unique Vertical Garden City concept of high-rise centers for business, education, leisure and residences. The concept has been applied in the company’s many leading-edge projects, including ARK Hills, Roppongi Hills and Toranomon Hills in Tokyo and the Shanghai World Financial Center. Mori Building is also engaged in real estate leasing, project management and consultation. Please visit www.mori.co.jp/en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190821005445/en/
Contact information
International Media Inquiries
Public Relations, Mori Building Co., Ltd.
Tel +81 (0)3-6406-6606
Fax +81 (0)3-6406-9306
E-mail koho@mori.co.jp
Weber Shandwick Japan
Kaya Tanabe (phone: +81 (0)90 7726 7027), Reina Matsushita (+81 (0)80 2375 0295),
Mayuko Harada (+81 (0)90 9006 4968) or Masashi Nonaka (+81 (0)80 1037 7879)
E-mail moribldg@webershandwick.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 20263.10.2026 17:50:00 EEST | Press release
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1b C-800-01 trial. The study evaluated botensilimab (BOT), Agenus’ multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), Agenus’ anti-PD-1 antibody. The results, including three-year survival and outcomes by sensitivity to platinum-based chemotherapy and by prior treatment, were presented at the 2026 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in Montréal, Canada. Among patients evaluable for efficacy, three-year overall survival was 48% (n=35), unchanged from the two-year estimate, suggesting durable clinical benefit in this population. Responses and long-term survival were observed in both platinum-sensitive and platinum-resistant or refractory disease. At the last follow-up, 25% of patients who received at least one dose of treatment (11 of 44) were alive
emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer2.10.2026 18:12:00 EEST | Press release
emnify, a global leader in IoT connectivity, today announced the appointments of Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001902751/en/ emnify Appoints Sacha Herrmann as Chief Financial Officer and Christian Friis as Chief Revenue Officer The appointments follow the recent naming of Kenneth De Spiegeleire as Chief Executive Officer and Frank Stoecker as Executive Chairman of the Board. Together, these leadership changes strengthen emnify financial, operational, and commercial capabilities as the company enters its next phase of international growth. “We have proven momentum. Our ambition is to now turn it into global category leadership,” said Kenneth De Spiegeleire, CEO of emnify. “That requires sharper focus, disciplined execution, and the right capabilities in the right seats. Sacha brings financial lead
Tacton Appoints Former IFS Executive Merlin Knott as Chief Commercial Officer to Accelerate Global Growth and Scale Beyond CPQ2.10.2026 16:00:00 EEST | Press release
Tacton, a global leader in Configure, Price, Quote (CPQ) software and configuration solutions for manufacturers of complex products, today announced the appointment of Merlin Knott as Chief Commercial Officer (CCO). In this role, Knott will lead Tacton’s global commercial organization, including marketing, sales, and pre-sales, aligning the teams responsible for bringing Tacton’s solutions to market, and driving value to its customers and partners globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261002794882/en/ Merlin Knott, Chief Commercial Officer, Tacton Knott joins Tacton with decades of experience building and scaling commercial organizations across the enterprise software industry. Most recently, he held senior leadership roles at IFS, the world’s leading provider of Industrial AI software, where he led global partner and channel operations before becoming President of the company’s Enterprise Service Manageme
EDW Presents 2026 Data Quality Award to Repeat Winner Domivest2.10.2026 16:00:00 EEST | Press release
European DataWarehouse (EDW) presented its fifth annual Data Quality Award at the 2026 TSI Congress in Berlin. This year, EDW's Best Data Quality – Deal of the Year (2026) award was presented to Domivest B.V. for its transaction Domi 2023-1 B.V., recognising the firm's outstanding commitment to accurate, complete, and consistent reporting. The award is based on EDW's proprietary data quality scoring methodology, which evaluates transactions against thousands of validation rules and checks. Data quality excellence is not a one-off achievement. The fact that the same issuers continue to rank among the top performers year after year demonstrates that superior data quality is the result of sustained commitment, robust processes, and ongoing investment. "Receiving the Data Quality Award for a second time means a great deal to us. Transparent, accurate loan-level data is key to investor trust in our transactions, and we are grateful to European DataWarehouse for recognising the work our trea
ILiAD Biotechnologies Expands BPZE1 Public Health and Commercial Potential with Publication of Pediatric Phase 2b Study in The Lancet Infectious Diseases2.10.2026 15:00:00 EEST | Press release
ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the publication of results from its Phase 2b SUPER (Stand Up to Pertussis) clinical trial in The Lancet Infectious Diseases. This randomized, double blind, placebo- and active-comparator-controlled trial demonstrated that BPZE1, a live attenuated intranasal pertussis vaccine, induced robust nasal mucosal immune responses in healthy children aged 6 through 17 years (LINK). The study demonstrated that a single intranasal dose of BPZE1 induced nasal mucosal immune responses against all Bordetella pertussis antigens tested and was well tolerated, both when administered alone and when co-administered with a tetanus-diphtheria-acellular pertussis (Tdap) booster vaccine. The multi-center Phase 2b trial enrolled 366 participants across 16 sites in the United Kingdom, Australia, and Costa Rica and included participants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
